Sumitomo Mitsui Trust Holdings, Inc. Arcturus Therapeutics Holdings Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

$143 Billion
Q1 2024

A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,276,519 shares of ARCT stock, worth $49.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,276,519

Previous 1,320,652 3.34%

Holding current value

$49.5 Million

Previous $41.6 Million 3.53%

% of portfolio

0.03%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$31.23 - $42.99 $1.38 Million - $1.9 Million	-44,133 Reduced 3.34%	1,276,519 $43.1 Million
Q4 2023 Jan 30, 2024	SELL	$17.71 - $32.97 $1.2 Million - $2.24 Million	-67,922 Reduced 4.89%	1,320,652 $41.6 Million
Q3 2023 Oct 30, 2023	SELL	$25.44 - $37.35 $416,147 - $610,971	-16,358 Reduced 1.16%	1,388,574 $35.5 Million
Q2 2023 Jul 31, 2023	SELL	$23.94 - $32.36 $392,448 - $530,477	-16,393 Reduced 1.15%	1,404,932 $40.3 Million
Q1 2023 Apr 27, 2023	SELL	$14.72 - $23.97 $408,259 - $664,807	-27,735 Reduced 1.91%	1,421,325 $34.1 Million

Q4 2022 Jan 30, 2023	SELL	$14.14 - $23.06 $146,419 - $238,786	-10,355 Reduced 0.71%	1,449,060 $24.6 Million
Q3 2022 Oct 21, 2022	BUY	$13.05 - $22.13 $303,034 - $513,880	23,221 Added 1.62%	1,459,415 $21.6 Million
Q2 2022 Jul 26, 2022	BUY	$12.26 - $31.17 $418,262 - $1.06 Million	34,116 Added 2.43%	1,436,194 $22.6 Million
Q1 2022 Apr 27, 2022	BUY	$17.64 - $39.57 $786,849 - $1.77 Million	44,606 Added 3.29%	1,402,078 $37.8 Million
Q4 2021 Feb 02, 2022	SELL	$34.2 - $47.56 $36,252 - $50,413	-1,060 Reduced 0.08%	1,357,472 $50.2 Million
Q3 2021 Oct 25, 2021	BUY	$27.88 - $58.25 $4 Million - $8.37 Million	143,631 Added 11.82%	1,358,532 $64.9 Million
Q2 2021 Aug 02, 2021	BUY	$25.79 - $42.11 $23.2 Million - $37.9 Million	899,089 Added 284.69%	1,214,901 $41.1 Million
Q1 2021 Apr 30, 2021	BUY	$38.75 - $86.92 $7.02 Million - $15.8 Million	181,208 Added 134.62%	315,812 $13 Million
Q4 2020 Feb 05, 2021	BUY	$34.61 - $123.66 $118,850 - $424,648	3,434 Added 2.62%	134,604 $5.84 Million
Q3 2020 Oct 30, 2020	SELL	$37.49 - $63.19 $569,173 - $959,350	-15,182 Reduced 10.37%	131,170 $5.63 Million
Q2 2020 Jul 27, 2020	SELL	$12.66 - $58.27 $1.38 Million - $6.33 Million	-108,714 Reduced 42.62%	146,352 $6.84 Million
Q1 2020 Apr 27, 2020	SELL	$9.31 - $18.26 $237,237 - $465,301	-25,482 Reduced 9.08%	255,066 $3.47 Million
Q4 2019 Jan 31, 2020	SELL	$8.93 - $12.41 $160,579 - $223,156	-17,982 Reduced 6.02%	280,548 $3.05 Million
Q3 2019 Oct 31, 2019	BUY	$8.8 - $14.5 $1.48 Million - $2.44 Million	168,556 Added 129.68%	298,530 $3.07 Million
Q2 2019 Jul 29, 2019	BUY	$5.78 - $9.79 $751,249 - $1.27 Million	129,974 New	129,974 $1.23 Million

Others Institutions Holding ARCT

# of Institutions

195

Shares Held

26.7M

Call Options Held

294K

Put Options Held

318K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $1.03B
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.

Account

Sumitomo Mitsui Trust Holdings, Inc. Arcturus Therapeutics Holdings Inc. Transaction History